KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Amortization of Deferred Charges (2017 - 2025)

Historic Amortization of Deferred Charges for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to $390000.0.

  • Cardlytics' Amortization of Deferred Charges rose 129.87% to $390000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 345.66%. This contributed to the annual value of $1.6 million for FY2024, which is 91.02% down from last year.
  • Cardlytics' Amortization of Deferred Charges amounted to $390000.0 in Q3 2025, which was up 129.87% from $399000.0 recorded in Q2 2025.
  • Cardlytics' Amortization of Deferred Charges' 5-year high stood at $5.2 million during Q4 2021, with a 5-year trough of -$882000.0 in Q1 2021.
  • Its 5-year average for Amortization of Deferred Charges is $476823.5, with a median of $403000.0 in 2022.
  • Over the last 5 years, Cardlytics' Amortization of Deferred Charges had its largest YoY gain of 14557.82% in 2022, and its largest YoY loss of 9220.35% in 2022.
  • Over the past 5 years, Cardlytics' Amortization of Deferred Charges (Quarter) stood at $5.2 million in 2021, then crashed by 92.2% to $403000.0 in 2022, then rose by 2.73% to $414000.0 in 2023, then dropped by 3.86% to $398000.0 in 2024, then decreased by 2.01% to $390000.0 in 2025.
  • Its Amortization of Deferred Charges stands at $390000.0 for Q3 2025, versus $399000.0 for Q2 2025 and $405000.0 for Q1 2025.